Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
CNY 10.64
(0.09%)
CNY 10.64
(0.09%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 38.74 Million CNY | -80.46% |
| 2022 | 198.25 Million CNY | -38.17% |
| 2021 | 320.63 Million CNY | -44.18% |
| 2020 | 574.44 Million CNY | -40.16% |
| 2019 | 960.05 Million CNY | -10.35% |
| 2018 | 1.07 Billion CNY | -1.77% |
| 2017 | 1.09 Billion CNY | 0.0% |
| 2016 | - CNY | -100.0% |
| 2015 | 83.75 Million CNY | -37.29% |
| 2014 | 133.55 Million CNY | -29.65% |
| 2013 | 189.85 Million CNY | 143.09% |
| 2012 | 78.1 Million CNY | 20.15% |
| 2011 | 65 Million CNY | 0.0% |
| 2010 | 65 Million CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 50 Million CNY | 0.0% |
| 2007 | 50 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 36.61 Million CNY | -0.2% |
| 2024 Q1 | 36.69 Million CNY | -5.29% |
| 2024 Q3 | 37.37 Million CNY | 2.08% |
| 2023 Q2 | 184.48 Million CNY | -7.57% |
| 2023 Q3 | 116.55 Million CNY | -36.82% |
| 2023 Q4 | 38.74 Million CNY | -66.76% |
| 2023 FY | 38.74 Million CNY | -80.46% |
| 2023 Q1 | 199.6 Million CNY | 0.68% |
| 2022 Q2 | 286.2 Million CNY | -8.69% |
| 2022 FY | 198.25 Million CNY | -38.17% |
| 2022 Q4 | 198.25 Million CNY | -30.77% |
| 2022 Q3 | 286.38 Million CNY | 0.06% |
| 2022 Q1 | 313.45 Million CNY | -2.24% |
| 2021 FY | 320.63 Million CNY | -44.18% |
| 2021 Q2 | 447.64 Million CNY | -22.54% |
| 2021 Q3 | 366.71 Million CNY | -18.08% |
| 2021 Q4 | 320.63 Million CNY | -12.57% |
| 2021 Q1 | 577.89 Million CNY | 0.6% |
| 2020 FY | 574.44 Million CNY | -40.16% |
| 2020 Q1 | 917.1 Million CNY | -4.47% |
| 2020 Q2 | 781.69 Million CNY | -14.77% |
| 2020 Q3 | 876.65 Million CNY | 12.15% |
| 2020 Q4 | 574.44 Million CNY | -34.47% |
| 2019 Q2 | 1.1 Billion CNY | 4.57% |
| 2019 FY | 960.05 Million CNY | -10.35% |
| 2019 Q4 | 960.05 Million CNY | -19.51% |
| 2019 Q3 | 1.19 Billion CNY | 7.97% |
| 2019 Q1 | 1.05 Billion CNY | -1.35% |
| 2018 Q4 | 1.07 Billion CNY | -7.21% |
| 2018 Q1 | 1.18 Billion CNY | 8.5% |
| 2018 FY | 1.07 Billion CNY | -1.77% |
| 2018 Q2 | 1.15 Billion CNY | -2.44% |
| 2018 Q3 | 1.15 Billion CNY | 0.01% |
| 2017 FY | 1.09 Billion CNY | 0.0% |
| 2017 Q4 | 1.09 Billion CNY | 445.1% |
| 2017 Q3 | 200 Million CNY | 0.0% |
| 2017 Q2 | 200 Million CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | -100.0% |
| 2016 Q3 | - CNY | -100.0% |
| 2016 Q2 | 17.95 Million CNY | -18.22% |
| 2016 Q1 | 21.95 Million CNY | -73.79% |
| 2015 Q4 | 83.75 Million CNY | -30.81% |
| 2015 Q2 | 119.3 Million CNY | 5.06% |
| 2015 Q1 | 113.55 Million CNY | -14.98% |
| 2015 FY | 83.75 Million CNY | -37.29% |
| 2015 Q3 | 121.05 Million CNY | 1.47% |
| 2014 Q1 | 148.05 Million CNY | -22.02% |
| 2014 Q2 | 132.75 Million CNY | -10.33% |
| 2014 Q4 | 133.55 Million CNY | 0.6% |
| 2014 Q3 | 132.75 Million CNY | 0.0% |
| 2014 FY | 133.55 Million CNY | -29.65% |
| 2013 Q1 | 91.45 Million CNY | 17.09% |
| 2013 Q2 | 137.2 Million CNY | 50.03% |
| 2013 Q3 | 165.25 Million CNY | 20.44% |
| 2013 Q4 | 189.85 Million CNY | 14.89% |
| 2013 FY | 189.85 Million CNY | 143.09% |
| 2012 Q3 | 138.75 Million CNY | 16.21% |
| 2012 Q2 | 119.4 Million CNY | 71.06% |
| 2012 FY | 78.1 Million CNY | 20.15% |
| 2012 Q1 | 69.8 Million CNY | 7.38% |
| 2012 Q4 | 78.1 Million CNY | -43.71% |
| 2011 Q3 | 65 Million CNY | 0.0% |
| 2011 Q2 | 65 Million CNY | 0.0% |
| 2011 Q1 | 65 Million CNY | 0.0% |
| 2011 Q4 | 65 Million CNY | 0.0% |
| 2011 FY | 65 Million CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q4 | 65 Million CNY | 0.0% |
| 2010 FY | 65 Million CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 Q3 | 50 Million CNY | 0.0% |
| 2009 Q4 | - CNY | -100.0% |
| 2009 FY | - CNY | -100.0% |
| 2009 Q2 | 50 Million CNY | 0.0% |
| 2008 Q4 | 50 Million CNY | 0.0% |
| 2008 FY | 50 Million CNY | 0.0% |
| 2007 FY | 50 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |